Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and fluorodeoxyglucose f18

technetium tc 99m hydroxymethylene diphosphonate has been researched along with fluorodeoxyglucose f18 in 18 studies

Compound Research Comparison

Studies
(technetium tc 99m hydroxymethylene diphosphonate)
Trials
(technetium tc 99m hydroxymethylene diphosphonate)
Recent Studies (post-2010)
(technetium tc 99m hydroxymethylene diphosphonate)
Studies
(fluorodeoxyglucose f18)
Trials
(fluorodeoxyglucose f18)
Recent Studies (post-2010) (fluorodeoxyglucose f18)
618358734,7712,16020,111

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (11.11)18.2507
2000's10 (55.56)29.6817
2010's6 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukumura, T; Ichiya, Y; Kawai, Y; Koga, H; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M1
Cho, I; Fukuchi, K; Hayashida, K; Imakita, S; Ishida, Y; Kume, N; Kumita, S; Shimotsu, Y; Takamiya, M; Toba, M1
Börner, AR; Flügel, M; Knapp, WH; Kühnel, G; Redeker, J; Weckesser, E1
Aoki, J; Endo, K; Ichikawa, A; Inoue, T; Koyama, K; Matsubara, K; Oriuchi, N; Sato, N; Suzuki, H; Tomiyoshi, K1
Fukuchi, K; Hayashida, K; Ishida, Y; Yamaguchi, M1
Cesnik, R; Frühwald, F; Leitha, T; Steiner, E1
Hamdan, A; Keller, A; Taylor, S; Toman, J1
Fogelman, I1
Kubota, T; Nakai, T; Nishimura, T; Okuyama, C; Suzuki, T; Taniike, K; Ushijima, Y; Yamada, K1
Abe, K; Baba, S; Hayashi, K; Honda, H; Koga, H; Kuwabara, Y; Sasaki, M; Takahashi, N1
Fujimoto, R; Fujita, T; Hara, T; Higashi, T; Ishizu, K; Kawase, S; Kawashima, H; Lyshchik, A; Nakamoto, Y; Saga, T; Togashi, K1
Arce, K; Assael, LA; Markiewicz, MR; Weissman, JL1
Chezal, JM; Dauplat, MM; Gouin, F; Heymann, D; Miot-Noirault, E; Redini, F1
Chong, A; Ha, JM; Hong, R; Kwon, SY1
Kim, SH; Song, BI; Won, KS1
De Marini, P; Fornecker, LM; Laplace, A; Matuszak, J; Namer, IJ1
Hamzah, F; Khoo, AC; Ong, CK1
Blondet, C; Heimburger, C; Matuszak, J; Somme, F1

Reviews

1 review(s) available for technetium tc 99m hydroxymethylene diphosphonate and fluorodeoxyglucose f18

ArticleYear
Imaging findings in bisphosphonate-related osteonecrosis of jaws.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2009, Volume: 67, Issue:5 Suppl

    Topics: Bone Density Conservation Agents; Diphosphonates; Fluorodeoxyglucose F18; Humans; Jaw Diseases; Magnetic Resonance Imaging; Osteonecrosis; Positron-Emission Tomography; Radiography, Panoramic; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed

2009

Trials

2 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and fluorodeoxyglucose f18

ArticleYear
Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
    European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:11

    Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate

2005
Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer.
    Annals of nuclear medicine, 2005, Volume: 19, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging

2005

Other Studies

15 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and fluorodeoxyglucose f18

ArticleYear
Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:2

    Topics: Adult; Bone Neoplasms; Deoxyglucose; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Ribs; Technetium Tc 99m Medronate; Tomography, Emission-Computed

1993
Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia.
    Annals of nuclear medicine, 1998, Volume: 12, Issue:3

    Topics: Bone Density; Facial Bones; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Glucose; Humans; Hyperplasia; Middle Aged; Radiopharmaceuticals; Sclerosis; Skull; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

1998
[Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography].
    Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:3

    Topics: Aged; Carbon Radioisotopes; Diagnosis, Differential; Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tissue Distribution; Tomography, Emission-Computed

2000
Usefulness of dual-head coincidence gamma camera with thick NaI crystals for nuclear oncology: comparison with dedicated PET camera and conventional gamma camera with thin NaI crystals.
    Annals of nuclear medicine, 2001, Volume: 15, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Iodide; Technetium Tc 99m Medronate; Tomography, Emission-Computed

2001
Discrepancy between Tc-99m HMDP bone scan and F-18 FDG positron emission tomographic images in a patient with small cell lung cancer.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:3

    Topics: Bone Marrow Neoplasms; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Ilium; Lung Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed

2003
Use of FDG-PET in the differential diagnosis of a single bone lesion in ovarian cancer.
    Clinical nuclear medicine, 2004, Volume: 29, Issue:3

    Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Pelvic Bones; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate

2004
Nuclear imaging of an extraskeletal retroperitoneal osteosarcoma: respective contribution of 18FDG-PET and (99m)Tc oxidronate (2005:1b).
    European radiology, 2005, Volume: 15, Issue:4

    Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Technetium Tc 99m Medronate

2005
Osteoblastic bone metastases in breast cancer: is not seeing believing?
    European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:11

    Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate

2005
Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET.
    Annals of nuclear medicine, 2006, Volume: 20, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging

2006
Relevance of the POS-1 orthotopic model as an "imaging model" for in vivo and simultaneous monitoring of tumor proliferation and bone remodeling in osteosarcoma.
    Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:1

    Topics: Animals; Bone Neoplasms; Bone Remodeling; Cell Growth Processes; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C3H; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate

2012
Variations in findings on (18) F-FDG PET/CT, Tc-99m HDP bone scan and WBC scan in chronic multifocal osteomyelitis.
    International journal of rheumatic diseases, 2014, Volume: 17, Issue:3

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Leukocyte Count; Lumbar Vertebrae; Male; Osteomyelitis; Positron-Emission Tomography; Radionuclide Imaging; Sternum; Technetium Tc 99m Medronate; Thoracic Vertebrae

2014
Colon visualization on (99m)Tc-HDP whole-body bone scan due to sigmoid colon cancer-related enterovesical fistula.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:1

    Topics: Aged; Bone and Bones; Carcinoma; Fluorodeoxyglucose F18; Humans; Incidental Findings; Intestinal Fistula; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Urinary Bladder Fistula; Whole Body Imaging

2015
Spleen Uptake on Bone Scan After Frequent Platelet and RBC Transfusions.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:10

    Topics: Bone and Bones; Erythrocyte Transfusion; Fluorodeoxyglucose F18; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Platelet Transfusion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen; Technetium Tc 99m Medronate; Young Adult

2016
Incidental Sclerosing Pneumocytoma Detected on Bone Scintigraphy.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:1

    Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Osteomyelitis; Positron Emission Tomography Computed Tomography; Pulmonary Sclerosing Hemangioma; Radiopharmaceuticals; Technetium Tc 99m Medronate

2017
Evaluation of Oxalate Osteopathy Secondary to Hyperoxaluria With 18F-FDG PET/CT and 99mTc-HMDP Bone Scan.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:2

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Hyperoxaluria, Primary; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Medronate

2019